Antiproliferative Effect of Lanreotide in Low Grade Neuroendocrine Neoplasms: Two Case Reports

Q23

  • Vaslamatzis, M.
  • Tegos, T.
  • Alevizopoulos, N.
  • Stathopoulos, C.
  • Argyrakos, T.
  • Kapou, T.
  • Patila, E.
  • Vlontzou, E.
  • Ioannidou, S.
  • Rontogianni, D.

  • Evangelismos Hospital, Athens, Greece

Neuroendocrinology 102(2):p 155-156, September-October 2015.
Copyright © 2015 S. Karger AG, Basel